EUVIMEDEUVIMED entdecken
Crossref

ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS)

Suzanna Edgar, Nurul Angelyn Zulhairy-Liong, Melina Ellis, Shuchi Trivedi, Danqing Zhu, Jeffrey Ochieng Odongo, Khean-Jin Goh, David Paul Capelle, Nortina Shahrizaila, Marina L Kennerson, Azlina Ahmad-Annuar

Neurogenetics · 2025

DOI: 10.1007/s10048-024-00798-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogenetics, 2025. Verfasst von Suzanna Edgar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Ataxin-2, Peptides, Trinucleotide Repeat Expansion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Malaysian Ministry of Education Fundamental Research Grant Scheme, ALS Association Seed Grant, Sydney Southeast Asia Centre Collaborative Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intermediate CAG repeats from 29 to 33 in the ATXN2 gene contributes to the risk of amyotrophic lateral sclerosis (ALS) in European and Asian populations. In this study, 148 ALS patients of multiethnic descent: Chinese (56.1%), Malay (24.3%), Indian (12.8%), others (6.8%) and 100 neurologically normal controls were screened for the ATXN2 CAG repeat expansion. The most common repeat length in both the controls and patients was 22. No familial ALS patients were positive for the intermediate repeat sizes (29-33), while four sporadic patients (2.8%) were positive, with one harbouring a rare ATXN2 homozygous 32 repeat expansion, and a likely pathogenic variant in SPAST. All four patients had limb-onset ALS. Despite representing the smallest ethnic group in our patient cohort, three of the four patients with intermediate repeat sizes were of Indian ancestry. This study, which is the first in Malaysia and Southeast Asia, shows that ATXN2 intermediate risk expansions are relevant to ALS in these populations and will help to inform future genetic testing strategies in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisAtaxin-2PeptidesTrinucleotide Repeat ExpansionAdultAgedFemaleHumansMaleMiddle AgedGenetic Predisposition to DiseaseMalaysiaSoutheast Asian People

Stichwörter der Autor:innen

ATXN2Amyotrophic lateral sclerosisHomozygous repeat expansionIntermediate repeat lengthMalaysia

Substanzen

Ataxin-2ATXN2 protein, humanPeptidespolyglutamine

Autor:innen und Institutionen

  • Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia.
  • Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia.
  • Northcott Neuroscience Laboratory, Sydney Local Health District ANZAC Research Institute, Sydney Local Health District Hospital Rd, Concord, NSW, 2137, Australia.
  • Molecular Medicine Laboratory, NSW Health Pathology, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia. nortina@um.edu.my.
  • Northcott Neuroscience Laboratory, Sydney Local Health District ANZAC Research Institute, Sydney Local Health District Hospital Rd, Concord, NSW, 2137, Australia. marina.kennerson@sydney.edu.au.

Förderung

  • Malaysian Ministry of Education Fundamental Research Grant Scheme
  • ALS Association Seed Grant
  • Sydney Southeast Asia Centre Collaborative Grant

Zitieren

APA

Edgar, S., Zulhairy-Liong, N. A., Ellis, M., Trivedi, S., Zhu, D., Odongo, J. O., Goh, K. J., Capelle, D. P., Shahrizaila, N., Kennerson, M. L., & Ahmad-Annuar, A. (2025). ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS). Neurogenetics. https://doi.org/10.1007/s10048-024-00798-0

Vancouver

Edgar S, Zulhairy-Liong NA, Ellis M, Trivedi S, Zhu D, Odongo JO, et al. ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS). Neurogenetics. 2025. doi:10.1007/s10048-024-00798-0

BibTeX
@article{Edgar2025,
  author = {Edgar, Suzanna and Zulhairy-Liong, Nurul Angelyn and Ellis, Melina and Trivedi, Shuchi and Zhu, Danqing and Odongo, Jeffrey Ochieng and Goh, Khean-Jin and Capelle, David Paul and Shahrizaila, Nortina and Kennerson, Marina L and Ahmad-Annuar, Azlina},
  title = {ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS)},
  journal = {Neurogenetics},
  year = {2025},
  doi = {10.1007/s10048-024-00798-0}
}
Kostenlos starten →